Back
OncoCyte Vs. ProPhase Labs Industry Stock Comparison
Sell
43
OCX
OncoCyte
Last Price:
2.57
Seasonality Move:
42.9%
Sell
8
PRPH
ProPhase Labs
Last Price:
0.75
Seasonality Move:
13.45%
Sell
43
OncoCyte (OCX)
is a Sell
Is OncoCyte a Buy, Sell or Hold?
- The current OncoCyte [OCX] share price is $2.53. The Score for OCX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- OCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
ProPhase Labs (PRPH)
is a Sell
Is ProPhase Labs a Buy, Sell or Hold?
- The current ProPhase Labs [PRPH] share price is $0.75. The Score for PRPH is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
- PRPH is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PRPH Stock Price Chart
What is ProPhase Labs's stock price today?
-
The ProPhase Labs share price today is $0.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
OCX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 34.8 | Sell |
| Chaikin Money Flow: | -56603 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.68 - 3.04) | Sell |
| Bollinger Bands (100): | (2.87 - 3.21) | Sell |
PRPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 19.12 | Sell |
| Chaikin Money Flow: | 88405 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.71 - 2.17) | Sell |
| Bollinger Bands (100): | (1.65 - 3.09) | Sell |
OCX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.64 | Sell |
| 20-day SMA: | 2.81 | Sell |
| 50-day SMA: | 2.95 | Sell |
| 200-day SMA: | 2.94 | Sell |
| 8-day EMA: | 2.67 | Sell |
| 20-day EMA: | 2.78 | Sell |
| 50-day EMA: | 2.91 | Sell |
| 200-day EMA: | 3.19 | Sell |
PRPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.76 | Sell |
| 20-day SMA: | 1.22 | Sell |
| 50-day SMA: | 1.91 | Sell |
| 200-day SMA: | 3.76 | Sell |
| 8-day EMA: | 0.81 | Sell |
| 20-day EMA: | 1.15 | Sell |
| 50-day EMA: | 1.75 | Sell |
| 200-day EMA: | 3.34 | Sell |
OncoCyte Earnings Growth & OCX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.
ProPhase Labs Earnings Growth & PRPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.43 per share.
OncoCyte Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProPhase Labs Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||